-
WHO's Newest Updates in Pharmaceutical GMP Guidelines
Saher Binte Haider
April 23, 2024
GMP is a fundamental concept in pharmaceutical manufacturing and distribution. Poor-quality medicinal products can lead to adverse effects, treatment failure, and even death. Implementing GMP assures that pharmaceutical products are produced with the high
-
The Future of GMP in the Pharmaceutical Industry
Saher Binte Haider
March 21, 2024
The pharmaceutical industries are continuously evolving, which is why the future of GMP is on the brink of significant change.
-
cGMP regulations in pharmaceutical industry
Muhammad Asim Niazi
June 14, 2023
Let’s look at some importance of GMP in pharma manufacturing and see how it benefits the pharma manufacturer.
-
InvestEU: EIB Agrees to a €18 Million Loan to Estonian Biotech Icosagen for Innovative R&D Technologies and New cGMP Production Facility
PharmaSources
February 09, 2023
The Estonian biopharmaceutical innovator Icosagen AS has reached a €18 million financing agreement with the EIB to further strengthen its drug discovery, development and production services.
-
Rokote Laboratories selects Exothera for GMP manufacturing of its second-generation coronavirus vaccine FINCoVac 2.0.
PharmaSources.com
April 07, 2022
Rokote Laboratories Finland Ltd., a vaccine development company focusing on a second-generation COVID-19 vaccine, and Exothera S.A. will collaborate to bring the intranasal coronavirus vaccine FINCoVac 2.0 to clinical Phase I/II trials.
-
GMP certification for Exothera further extends its viral vector manufacturing capacity
PharmaSources.com
March 24, 2022
Exothera S.A., a CDMO specialized in the development and manufacture of viral vectors for vaccines and gene therapies, received Good Manufacturing Practices (GMP) certification from the Federal Agency for Medicines and Health Products...
-
Nanoform Signs GMP Manufacturing Program with TargTex
contractpharma
February 04, 2022
Aims to enhance TargTex’s Glioblastoma multiforme drug candidate.
-
Successful Groundbreaking Ceremony for GenScript ProBio to Expand Commercial cGMP Plasmid and Viral Vector Manufacturing Facility in Zhenjiang, China
prnasia
January 21, 2022
GenScript ProBio, a global antibody and gene therapy contract development and manufacturing organization (CDMO), has announced 2022 manufacturing expansion plans to meet the increasing demand for commercial cGMP...
-
WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug Substance Facility
prnasia
January 18, 2022
WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by South Korea's Ministry...
-
Panaxia's medical cannabis facility in Malta gains EU-GMP standard
CPhIonline
January 06, 2022
This second facility gives the company a significant power multiplier for export capacity and geographical reach.